对围产期失眠的认知行为疗法的有效性:对随机对照试验的元分析
Shuya Feng1, Bingqin Dai2, Huawei Li1
1School of Nursing, Qingdao University, Qingdao, Shandong China.
Sleep and biological rhythms
|March 25, 2024
概括
失眠的认知行为疗法 (CBT-I) 显著改善睡眠质量,并减少围产期妇女的抑郁症状. 这种疗法证明了持久的疗效,为孕产妇的心理健康和产前期的睡眠提供了持久的益处.
科学领域:
- 围产期心理健康问题
- 睡眠医学 睡眠医学
- 心理治疗研究 心理治疗研究
背景情况:
- 失眠是影响围产期妇女的一个普遍问题,影响母亲的福祉和婴儿护理.
- 失眠的认知行为治疗 (CBT-I) 是慢性失眠的第一线治疗方法.
- 特别是在围产期人口中,CBT-I的有效性和持久性需要进一步研究.
研究的目的:
- 系统地评估CBT-I在改善围产期妇女失眠症状方面的有效性.
- 评估CBT-I对二次结果的影响,包括抑郁症和整体睡眠质量.
- 为了确定CBT-I在围产期失眠的持久疗效.
主要方法:
- 进行了随机对照试验 (RCT) 的元分析.
- 研究通过对PubMed,Embase,PsycINFO和Web of Science的全面搜索来确定这些研究.
- 失眠严重程度指数 (ISI) 是主要的结果指标,爱丁堡产后抑郁症量表 (EPDS) 和匹兹堡睡眠质量指数 (PSQI) 是次要的结果.
主要成果:
- 正如ISI指出的那样,CBT-I显著改善了失眠症状 (SMD = -0.62).
- 在随访时,该疗法在治疗失眠方面表现出持久的疗效 (SMD = -0.47).
- 在干预后,人们观察到抑郁症 (EPDS,SMD = -0.31) 和睡眠质量 (PSQI,SMD = -0.82) 的显著改善.
结论:
- CBT-I是一种有效的干预措施,可以缓解失眠,抑郁症,并改善围产期妇女的睡眠质量.
- CBT-I对失眠的积极影响是持久的,提供持续的好处.
- 建议进行进一步的大规模RCT,以证实这些发现,并探索治疗疗效的潜在修饰因素.
更多相关视频
11:50Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
Published on: January 7, 2020
26.4K
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
676
相关概念视频
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
01:27Insomnia
85
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
85
01:14CNS Depressants: Barbiturates and Benzodiazepines
259
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
259
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171